Angiogenesis as a therapeutic target

被引：2171

作者：

Ferrara, N

Kerbel, RS

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

[2] Univ Toronto, Toronto, ON M5G 2M9, Canada

[3] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M5G 2M9, Canada

来源：

NATURE | 2005年 / 438卷 / 7070期

基金：

加拿大健康研究院; 美国国家卫生研究院;

关键词：

D O I：

10.1038/nature04483

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration. Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries. Therapeutic angiogenesis ( promoting new vessel growth to treat ischaemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first.

引用

页码：967 / 974

页数：8

共 99 条

[1] VASCULAR REACTIONS OF NORMAL AND MALIGNANT TISSUES INVIVO .1. VASCULAR REACTIONS OF MICE TO WOUNDS AND TO NORMAL AND NEOPLASTIC TRANSPLANTS
ALGIRE, GH
CHALKLEY, HW
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1945, 6 (01) : 73 - 85
[2] Isolation of putative progenitor endothelial cells for angiogenesis
Asahara, T
Murohara, T
Sullivan, A
Silver, M
vanderZee, R
Li, T
Witzenbichler, B
Schatteman, G
Isner, JM
[J]. SCIENCE, 1997, 275 (5302) : 964 - 967
[3] Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
Bender, JG
Cooney, EM
Kandel, JJ
Yamashiro, DJ
[J]. DRUG RESISTANCE UPDATES, 2004, 7 (4-5) : 289 - 300
[4] Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Bergers, G
Song, S
Meyer-Morse, N
Bergsland, E
Hanahan, D
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) : 1287 - 1295
[5] Bertolini F, 2003, CANCER RES, V63, P4342
[6] Browder T, 2000, CANCER RES, V60, P1878
[7] Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
Brugarolas, J
Kaelin, WG
[J]. CANCER CELL, 2004, 6 (01) : 7 - 10
[8] Common mechanisms of nerve and blood vessel wiring
Carmeliet, P
Tessier-Lavigne, M
[J]. NATURE, 2005, 436 (7048) : 193 - 200
[9] Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen
Chen, Y
Wiesmann, C
Fuh, G
Li, B
Christinger, HW
McKay, P
de Vos, AM
Lowman, HB
[J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (04) : 865 - 881
[10] Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells
De Palma, M
Venneri, MA
Roca, C
Naldini, L
[J]. NATURE MEDICINE, 2003, 9 (06) : 789 - 795

← 1 2 3 4 5 6 7 8 9 10 →